These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35594457)

  • 21. The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis.
    Silny W; Czarnecka-Operacz M; Silny P
    Acta Dermatovenerol Croat; 2005; 13(4):219-24. PubMed ID: 16356394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of patient (POEM), observer (EASI, SASSAD, TIS) and corneometry measures of emollient effectiveness in children with eczema: findings from the COMET feasibility trial.
    Ridd MJ; Gaunt DM; Guy RH; Redmond NM; Garfield K; Hollinghurst S; Ball N; Shaw L; Purdy S; Metcalfe C
    Br J Dermatol; 2018 Aug; 179(2):362-370. PubMed ID: 29476542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
    Eichenfield LF; Tom WL; Chamlin SL; Feldman SR; Hanifin JM; Simpson EL; Berger TG; Bergman JN; Cohen DE; Cooper KD; Cordoro KM; Davis DM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Silverman RA; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Sidbury R
    J Am Acad Dermatol; 2014 Feb; 70(2):338-51. PubMed ID: 24290431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study.
    Alexis A; de Bruin-Weller M; Weidinger S; Soong W; Barbarot S; Ionita I; Zhang F; Valdez H; Clibborn C; Yin N
    Dermatol Ther (Heidelb); 2022 Mar; 12(3):771-785. PubMed ID: 35297025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dupilumab for children and adolescents with atopic dermatitis: An Asian perspective.
    Chia SY; Wee LWY; Koh MJA
    Dermatol Ther; 2021 May; 34(3):e14933. PubMed ID: 33751751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
    Patruno C; Stingeni L; Hansel K; Ferrucci SM; Tavecchio S; Fabbrocini G; Nisticò SP; Foti C; De Prezzo S; Napolitano M
    Dermatol Ther; 2020 May; 33(3):e13290. PubMed ID: 32125741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Simpson EL; Sinclair R; Forman S; Wollenberg A; Aschoff R; Cork M; Bieber T; Thyssen JP; Yosipovitch G; Flohr C; Magnolo N; Maari C; Feeney C; Biswas P; Tatulych S; Valdez H; Rojo R
    Lancet; 2020 Jul; 396(10246):255-266. PubMed ID: 32711801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis.
    Baek JH; Park CW; Choi KM; Yang YS; Lee SY; Koh JS; Chung BY; Kim HO; Park GH
    Int J Dermatol; 2015 Dec; 54(12):1382-9. PubMed ID: 25556325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
    Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone.
    Silverberg JI; Thyssen JP; Paller AS; Drucker AM; Wollenberg A; Lee KH; Kabashima K; Todd G; Schmid-Grendelmeier P; Bieber T
    Allergy; 2017 Dec; 72(12):2026-2030. PubMed ID: 28605026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot comparison study of four clinician-rated atopic dermatitis severity scales.
    Zhao CY; Tran AQ; Lazo-Dizon JP; Kim J; Daniel BS; Venugopal SS; Rhodes LM; Law MG; Murrell DF
    Br J Dermatol; 2015 Aug; 173(2):488-97. PubMed ID: 25891151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship and probabilistic stratification of Eczema Area and Severity Index and objective Scoring Atopic Dermatitis severity scores for atopic dermatitis.
    Hurault G; Schram ME; Roekevisch E; Spuls PI; Tanaka RJ
    Br J Dermatol; 2018 Oct; 179(4):1003-1005. PubMed ID: 29945301
    [No Abstract]   [Full Text] [Related]  

  • 34. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alefacept for moderate to severe atopic dermatitis: a pilot study in adults.
    Moul DK; Routhouska SB; Robinson MR; Korman NJ
    J Am Acad Dermatol; 2008 Jun; 58(6):984-9. PubMed ID: 18395294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
    Guttman-Yassky E; Teixeira HD; Simpson EL; Papp KA; Pangan AL; Blauvelt A; Thaçi D; Chu CY; Hong HC; Katoh N; Paller AS; Calimlim B; Gu Y; Hu X; Liu M; Yang Y; Liu J; Tenorio AR; Chu AD; Irvine AD
    Lancet; 2021 Jun; 397(10290):2151-2168. PubMed ID: 34023008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus.
    Abuabara K; Nicholls SG; Langan SM; Guttman-Yassky E; Reynolds NJ; Paller AS; Brown SJ;
    Br J Dermatol; 2021 Jul; 185(1):203-205. PubMed ID: 33570761
    [No Abstract]   [Full Text] [Related]  

  • 38. Common Atopic Dermatitis Rating Scales: A Practical Approach and Brief Review [Formula: see text].
    Yang YB; Lynde CW; Fleming P
    J Cutan Med Surg; 2020; 24(4):399-404. PubMed ID: 32396013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis.
    Breuer K; Braeutigam M; Kapp A; Werfel T
    Dermatology; 2004; 209(4):314-20. PubMed ID: 15539895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysis.
    Lee HH; Patel KR; Rastogi S; Singam V; Vakharia PP; Chopra R; Silverberg JI
    J Am Acad Dermatol; 2020 Jan; 82(1):62-71. PubMed ID: 31202874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.